Prognosis
Ghana Drugmakers Approach AstraZeneca on Vaccine Production
- Industry says negotiations ongoing about intellectual property
- Local manufacturing seen as a solution to vaccine inequality
This article is for subscribers only.
Ghana’s pharmaceutical industry has approached AstraZeneca Plc about acquiring the rights to manufacture the U.K. company’s vaccine locally, a move that could boost supplies and speed up the inoculation program in the country.
The West African nation has to date received 966,850 doses of the inoculations from sources including the Covax initiative, which aims to ensure equitable access to Covid-19 shots, and has been allocated about 1.4 million more. That’s only enough to protect a fraction of a population of more than 30 million.